Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-based Injectable Drugs Market Size Growth Rate by Type, 2024 VS 2022 VS 2034
1.2.2 Brand
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Peptide-based Injectable Drugs Market Size Growth Rate by Application, 2024 VS 2022 VS 2034
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide-based Injectable Drugs Market Perspective (2024-2034)
2.2 Global Peptide-based Injectable Drugs Growth Trends by Region
2.2.1 Peptide-based Injectable Drugs Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Peptide-based Injectable Drugs Historic Market Size by Region (2024-2024)
2.2.3 Peptide-based Injectable Drugs Forecasted Market Size by Region (2024-2034)
2.3 Peptide-based Injectable Drugs Market Dynamics
2.3.1 Peptide-based Injectable Drugs Industry Trends
2.3.2 Peptide-based Injectable Drugs Market Drivers
2.3.3 Peptide-based Injectable Drugs Market Challenges
2.3.4 Peptide-based Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Peptide-based Injectable Drugs by Players
3.1.1 Global Peptide-based Injectable Drugs Revenue by Players (2024-2024)
3.1.2 Global Peptide-based Injectable Drugs Revenue Market Share by Players (2024-2024)
3.2 Global Peptide-based Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Peptide-based Injectable Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Peptide-based Injectable Drugs Market Concentration Ratio
3.4.1 Global Peptide-based Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-based Injectable Drugs Revenue in 2022
3.5 Global Key Players of Peptide-based Injectable Drugs Head office and Area Served
3.6 Global Key Players of Peptide-based Injectable Drugs, Product and Application
3.7 Global Key Players of Peptide-based Injectable Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-based Injectable Drugs Breakdown Data by Type
4.1 Global Peptide-based Injectable Drugs Historic Market Size by Type (2024-2024)
4.2 Global Peptide-based Injectable Drugs Forecasted Market Size by Type (2024-2034)
5 Peptide-based Injectable Drugs Breakdown Data by Application
5.1 Global Peptide-based Injectable Drugs Historic Market Size by Application (2024-2024)
5.2 Global Peptide-based Injectable Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Peptide-based Injectable Drugs Market Size (2024-2034)
6.2 North America Peptide-based Injectable Drugs Market Size by Type
6.2.1 North America Peptide-based Injectable Drugs Market Size by Type (2024-2024)
6.2.2 North America Peptide-based Injectable Drugs Market Size by Type (2024-2034)
6.2.3 North America Peptide-based Injectable Drugs Market Share by Type (2024-2034)
6.3 North America Peptide-based Injectable Drugs Market Size by Application
6.3.1 North America Peptide-based Injectable Drugs Market Size by Application (2024-2024)
6.3.2 North America Peptide-based Injectable Drugs Market Size by Application (2024-2034)
6.3.3 North America Peptide-based Injectable Drugs Market Share by Application (2024-2034)
6.4 North America Peptide-based Injectable Drugs Market Size by Country
6.4.1 North America Peptide-based Injectable Drugs Market Size by Country: 2024 VS 2022 VS 2034
6.4.2 North America Peptide-based Injectable Drugs Market Size by Country (2024-2024)
6.4.3 North America Peptide-based Injectable Drugs Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Peptide-based Injectable Drugs Market Size (2024-2034)
7.2 Europe Peptide-based Injectable Drugs Market Size by Type
7.2.1 Europe Peptide-based Injectable Drugs Market Size by Type (2024-2024)
7.2.2 Europe Peptide-based Injectable Drugs Market Size by Type (2024-2034)
7.2.3 Europe Peptide-based Injectable Drugs Market Share by Type (2024-2034)
7.3 Europe Peptide-based Injectable Drugs Market Size by Application
7.3.1 Europe Peptide-based Injectable Drugs Market Size by Application (2024-2024)
7.3.2 Europe Peptide-based Injectable Drugs Market Size by Application (2024-2034)
7.3.3 Europe Peptide-based Injectable Drugs Market Share by Application (2024-2034)
7.4 Europe Peptide-based Injectable Drugs Market Size by Country
7.4.1 Europe Peptide-based Injectable Drugs Market Size by Country: 2024 VS 2022 VS 2034
7.4.2 Europe Peptide-based Injectable Drugs Market Size by Country (2024-2024)
7.4.3 Europe Peptide-based Injectable Drugs Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Peptide-based Injectable Drugs Market Size (2024-2034)
8.2 China Peptide-based Injectable Drugs Market Size by Type
8.2.1 China Peptide-based Injectable Drugs Market Size by Type (2024-2024)
8.2.2 China Peptide-based Injectable Drugs Market Size by Type (2024-2034)
8.2.3 China Peptide-based Injectable Drugs Market Share by Type (2024-2034)
8.3 China Peptide-based Injectable Drugs Market Size by Application
8.3.1 China Peptide-based Injectable Drugs Market Size by Application (2024-2024)
8.3.2 China Peptide-based Injectable Drugs Market Size by Application (2024-2034)
8.3.3 China Peptide-based Injectable Drugs Market Share by Application (2024-2034)
9 Asia (excluding China)
9.1 Asia Peptide-based Injectable Drugs Market Size (2024-2034)
9.2 Asia Peptide-based Injectable Drugs Market Size by Type
9.2.1 Asia Peptide-based Injectable Drugs Market Size by Type (2024-2024)
9.2.2 Asia Peptide-based Injectable Drugs Market Size by Type (2024-2034)
9.2.3 Asia Peptide-based Injectable Drugs Market Share by Type (2024-2034)
9.3 Asia Peptide-based Injectable Drugs Market Size by Application
9.3.1 Asia Peptide-based Injectable Drugs Market Size by Application (2024-2024)
9.3.2 Asia Peptide-based Injectable Drugs Market Size by Application (2024-2034)
9.3.3 Asia Peptide-based Injectable Drugs Market Share by Application (2024-2034)
9.4 Asia Peptide-based Injectable Drugs Market Size by Region
9.4.1 Asia Peptide-based Injectable Drugs Market Size by Region: 2024 VS 2022 VS 2034
9.4.2 Asia Peptide-based Injectable Drugs Market Size by Region (2024-2024)
9.4.3 Asia Peptide-based Injectable Drugs Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size (2024-2034)
10.2 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Type (2024-2024)
10.2.2 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Share by Type (2024-2034)
10.3 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Application (2024-2024)
10.3.2 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Share by Application (2024-2034)
10.4 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Country: 2024 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Country (2024-2024)
10.4.3 Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide-based Injectable Drugs Introduction
11.1.4 Sanofi Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.1.5 Sanofi Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Peptide-based Injectable Drugs Introduction
11.2.4 Teva Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.2.5 Teva Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide-based Injectable Drugs Introduction
11.3.4 Novo Nordisk Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.3.5 Novo Nordisk Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide-based Injectable Drugs Introduction
11.4.4 Takeda Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.4.5 Takeda Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide-based Injectable Drugs Introduction
11.5.4 Eli Lilly Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.5.5 Eli Lilly Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide-based Injectable Drugs Introduction
11.6.4 AstraZeneca Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.6.5 AstraZeneca Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide-based Injectable Drugs Introduction
11.7.4 Novartis Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.7.5 Novartis Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide-based Injectable Drugs Introduction
11.8.4 AbbVie Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.8.5 AbbVie Recent Developments
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide-based Injectable Drugs Introduction
11.9.4 Ipsen Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.9.5 Ipsen Recent Developments
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide-based Injectable Drugs Introduction
11.10.4 Ferring Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.10.5 Ferring Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Peptide-based Injectable Drugs Introduction
11.11.4 Merck Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.11.5 Merck Recent Developments
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide-based Injectable Drugs Introduction
11.12.4 The Medicines Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.12.5 The Medicines Recent Developments
11.13 Roche
11.13.1 Roche Company Details
11.13.2 Roche Business Overview
11.13.3 Roche Peptide-based Injectable Drugs Introduction
11.13.4 Roche Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.13.5 Roche Recent Developments
11.14 J & J
11.14.1 J & J Company Details
11.14.2 J & J Business Overview
11.14.3 J & J Peptide-based Injectable Drugs Introduction
11.14.4 J & J Revenue in Peptide-based Injectable Drugs Business (2024-2024)
11.14.5 J & J Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peptide-based Injectable Drugs Market Size Growth Rate by Type (US$ Million), 2024 VS 2022 VS 2034
Table 2. Key Players of Brand
Table 3. Key Players of Generic Drug
Table 4. Global Peptide-based Injectable Drugs Market Size Growth Rate by Application (US$ Million), 2024 VS 2022 VS 2034
Table 5. Global Peptide-based Injectable Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Peptide-based Injectable Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 7. Global Peptide-based Injectable Drugs Market Share by Region (2024-2024)
Table 8. Global Peptide-based Injectable Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Peptide-based Injectable Drugs Market Share by Region (2024-2034)
Table 10. Peptide-based Injectable Drugs Market Trends
Table 11. Peptide-based Injectable Drugs Market Drivers
Table 12. Peptide-based Injectable Drugs Market Challenges
Table 13. Peptide-based Injectable Drugs Market Restraints
Table 14. Global Peptide-based Injectable Drugs Revenue by Players (2024-2024) & (US$ Million)
Table 15. Global Peptide-based Injectable Drugs Revenue Share by Players (2024-2024)
Table 16. Global Top Peptide-based Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Injectable Drugs as of 2022)
Table 17. Global Peptide-based Injectable Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Peptide-based Injectable Drugs Revenue (CR5 and HHI) & (2024-2024)
Table 19. Global Key Players of Peptide-based Injectable Drugs, Headquarters and Area Served
Table 20. Global Key Players of Peptide-based Injectable Drugs, Product and Application
Table 21. Global Key Players of Peptide-based Injectable Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peptide-based Injectable Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 24. Global Peptide-based Injectable Drugs Revenue Market Share by Type (2024-2024)
Table 25. Global Peptide-based Injectable Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Peptide-based Injectable Drugs Revenue Market Share by Type (2024-2034)
Table 27. Global Peptide-based Injectable Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 28. Global Peptide-based Injectable Drugs Revenue Share by Application (2024-2024)
Table 29. Global Peptide-based Injectable Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Peptide-based Injectable Drugs Revenue Share by Application (2024-2034)
Table 31. North America Peptide-based Injectable Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 32. North America Peptide-based Injectable Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 33. North America Peptide-based Injectable Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 34. North America Peptide-based Injectable Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 35. North America Peptide-based Injectable Drugs Growth Rate (CAGR) by Country (US$ Million): 2024 VS 2022 VS 2034
Table 36. North America Peptide-based Injectable Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 37. North America Peptide-based Injectable Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe Peptide-based Injectable Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 39. Europe Peptide-based Injectable Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 40. Europe Peptide-based Injectable Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 41. Europe Peptide-based Injectable Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 42. Europe Peptide-based Injectable Drugs Growth Rate (CAGR) by Country (US$ Million): 2024 VS 2022 VS 2034
Table 43. Europe Peptide-based Injectable Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 44. Europe Peptide-based Injectable Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 45. China Peptide-based Injectable Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 46. China Peptide-based Injectable Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 47. China Peptide-based Injectable Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 48. China Peptide-based Injectable Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 49. Asia Peptide-based Injectable Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 50. Asia Peptide-based Injectable Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 51. Asia Peptide-based Injectable Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 52. Asia Peptide-based Injectable Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 53. Asia Peptide-based Injectable Drugs Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 54. Asia Peptide-based Injectable Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 55. Asia Peptide-based Injectable Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Growth Rate (CAGR) by Country (US$ Million): 2024 VS 2022 VS 2034
Table 61. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Peptide-based Injectable Drugs Product
Table 66. Sanofi Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 67. Sanofi Recent Developments
Table 68. Teva Company Details
Table 69. Teva Business Overview
Table 70. Teva Peptide-based Injectable Drugs Product
Table 71. Teva Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 72. Teva Recent Developments
Table 73. Novo Nordisk Company Details
Table 74. Novo Nordisk Business Overview
Table 75. Novo Nordisk Peptide-based Injectable Drugs Product
Table 76. Novo Nordisk Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 77. Novo Nordisk Recent Developments
Table 78. Takeda Company Details
Table 79. Takeda Business Overview
Table 80. Takeda Peptide-based Injectable Drugs Product
Table 81. Takeda Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 82. Takeda Recent Developments
Table 83. Eli Lilly Company Details
Table 84. Eli Lilly Business Overview
Table 85. Eli Lilly Peptide-based Injectable Drugs Product
Table 86. Eli Lilly Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 87. Eli Lilly Recent Developments
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Peptide-based Injectable Drugs Product
Table 91. AstraZeneca Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 92. AstraZeneca Recent Developments
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Peptide-based Injectable Drugs Product
Table 96. Novartis Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 97. Novartis Recent Developments
Table 98. AbbVie Company Details
Table 99. AbbVie Business Overview
Table 100. AbbVie Peptide-based Injectable Drugs Product
Table 101. AbbVie Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 102. AbbVie Recent Developments
Table 103. Ipsen Company Details
Table 104. Ipsen Business Overview
Table 105. Ipsen Peptide-based Injectable Drugs Product
Table 106. Ipsen Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 107. Ipsen Recent Developments
Table 108. Ferring Company Details
Table 109. Ferring Business Overview
Table 110. Ferring Peptide-based Injectable Drugs Product
Table 111. Ferring Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 112. Ferring Recent Developments
Table 113. Merck Company Details
Table 114. Merck Business Overview
Table 115. Merck Peptide-based Injectable Drugs Product
Table 116. Merck Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 117. Merck Recent Developments
Table 118. The Medicines Company Details
Table 119. The Medicines Business Overview
Table 120. The Medicines Peptide-based Injectable Drugs Product
Table 121. The Medicines Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 122. The Medicines Recent Developments
Table 123. Roche Company Details
Table 124. Roche Business Overview
Table 125. Roche Peptide-based Injectable Drugs Product
Table 126. Roche Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 127. Roche Recent Developments
Table 128. J & J Company Details
Table 129. J & J Business Overview
Table 130. J & J Peptide-based Injectable Drugs Product
Table 131. J & J Revenue in Peptide-based Injectable Drugs Business (2024-2024) & (US$ Million)
Table 132. J & J Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide-based Injectable Drugs Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Peptide-based Injectable Drugs Market Share by Type: 2022 VS 2034
Figure 3. Brand Features
Figure 4. Generic Drug Features
Figure 5. Global Peptide-based Injectable Drugs Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Figure 6. Global Peptide-based Injectable Drugs Market Share by Application: 2022 VS 2034
Figure 7. Cancer Case Studies
Figure 8. Metabolic Disorders Case Studies
Figure 9. Central Nervous System Case Studies
Figure 10. Other Case Studies
Figure 11. Peptide-based Injectable Drugs Report Years Considered
Figure 12. Global Peptide-based Injectable Drugs Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 13. Global Peptide-based Injectable Drugs Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 14. Global Peptide-based Injectable Drugs Market Share by Region: 2022 VS 2034
Figure 15. Global Peptide-based Injectable Drugs Market Share by Players in 2022
Figure 16. Global Top Peptide-based Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Injectable Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Peptide-based Injectable Drugs Revenue in 2022
Figure 18. North America Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 19. North America Peptide-based Injectable Drugs Market Share by Type (2024-2034)
Figure 20. North America Peptide-based Injectable Drugs Market Share by Application (2024-2034)
Figure 21. North America Peptide-based Injectable Drugs Market Share by Country (2024-2034)
Figure 22. United States Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Canada Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Peptide-based Injectable Drugs Market Size YoY (2024-2034) & (US$ Million)
Figure 25. Europe Peptide-based Injectable Drugs Market Share by Type (2024-2034)
Figure 26. Europe Peptide-based Injectable Drugs Market Share by Application (2024-2034)
Figure 27. Europe Peptide-based Injectable Drugs Market Share by Country (2024-2034)
Figure 28. Germany Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. France Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. U.K. Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Italy Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Russia Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Nordic Countries Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. China Peptide-based Injectable Drugs Market Size YoY (2024-2034) & (US$ Million)
Figure 35. China Peptide-based Injectable Drugs Market Share by Type (2024-2034)
Figure 36. China Peptide-based Injectable Drugs Market Share by Application (2024-2034)
Figure 37. Asia Peptide-based Injectable Drugs Market Size YoY (2024-2034) & (US$ Million)
Figure 38. Asia Peptide-based Injectable Drugs Market Share by Type (2024-2034)
Figure 39. Asia Peptide-based Injectable Drugs Market Share by Application (2024-2034)
Figure 40. Asia Peptide-based Injectable Drugs Market Share by Region (2024-2034)
Figure 41. Japan Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. South Korea Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. China Taiwan Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Southeast Asia Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. India Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Australia Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Size YoY (2024-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Share by Type (2024-2034)
Figure 49. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Share by Application (2024-2034)
Figure 50. Middle East, Africa, and Latin America Peptide-based Injectable Drugs Market Share by Country (2024-2034)
Figure 51. Brazil Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 52. Mexico Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 53. Turkey Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 55. Israel Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 56. GCC Countries Peptide-based Injectable Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 58. Teva Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 59. Novo Nordisk Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 60. Takeda Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 61. Eli Lilly Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 62. AstraZeneca Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 63. Novartis Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 64. AbbVie Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 65. Ipsen Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 66. Ferring Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 67. Merck Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 68. The Medicines Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 69. Roche Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 70. J & J Revenue Growth Rate in Peptide-based Injectable Drugs Business (2024-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed